Literature DB >> 2274

Circulating levels of prolactin in human breast cancer.

N A Sheth, K J Ranadive, J N Suraiya, A R Sheth.   

Abstract

Serum prolactin concentrations were measured by radioimmunoassays in 98 patients with established carcinoma of breast, 12 patients with cystic mastitis and 10 patients with gynaecomastia and compared with that of age matched normal control women. The serum prolactin levels in the patients with breast cancer, gynaecomastia or cystic mastitis were observed to be similar to that in normal women. It was interesting to note that the levels of prolactin in the luteal phase of the cycle were higher than that in the early follicular phase in normal women.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 2274      PMCID: PMC2024836          DOI: 10.1038/bjc.1975.145

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  18 in total

1.  Adrenalectomy and hypophysectomy for advanced cancer of the breast.

Authors:  H J ATKINS; M A FALCONER; J L HAYWARD; K S MACLEAN; P H SCHURR; P ARMITAGE
Journal:  Lancet       Date:  1960-05-28       Impact factor: 79.321

2.  Plasma prolactin and breast cancer.

Authors:  R G Wilson; R Buchan; M M Roberts; A P Forrest; A R Boyns; E N Cole; K Griffiths
Journal:  Cancer       Date:  1974-05       Impact factor: 6.860

3.  Mammotropic effect of prolactin enhanced by thyroidectomy.

Authors:  I Mittra
Journal:  Nature       Date:  1974-04-05       Impact factor: 49.962

4.  Plasma prolactin in breast cancer.

Authors:  A R Boyns; E N Cole; K Griffiths; M M Roberts; R Buchan; R G Wilson; A P Forrest
Journal:  Eur J Cancer       Date:  1973-02       Impact factor: 9.162

5.  [Evolution of serum prolactin levels during menstrual cycle].

Authors:  M Vekemans; P Delvoye; M L'Hermite; C Robyn
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1972-11-13

6.  Circulating prolactin levels during the menstrual cycle: episodic release and diurnal variation.

Authors:  Y Ehara; T Siler; G VandenBerg; Y N Sinha; S S Yen
Journal:  Am J Obstet Gynecol       Date:  1973-12-01       Impact factor: 8.661

7.  Human prolactin: 24-hour pattern with increased release during sleep.

Authors:  J F Sassin; A G Frantz; E D Weitzman; S Kapen
Journal:  Science       Date:  1972-09-29       Impact factor: 47.728

8.  Inhibition of mammary tumorigenesis by ergot alkaloids and promotion of mammary tumorigenesis by pituitary isografts in adreno-ovariectomized mice.

Authors:  R Yanai; H Nagasawa
Journal:  J Natl Cancer Inst       Date:  1972-03       Impact factor: 13.506

9.  Circadian periodicity of serum prolactin concentration in man.

Authors:  J Nokin; M Vekemans; M L'Hermite; C Robyn
Journal:  Br Med J       Date:  1972-09-02

Review 10.  Prolactin and mammary gland carcinogenesis. The problem of human prolactin.

Authors:  L M Boot
Journal:  Int J Cancer       Date:  1970-03-15       Impact factor: 7.396

View more
  7 in total

Review 1.  Epidemiology and endocrinology of benign breast disease.

Authors:  D Y Wang; I S Fentiman
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

Review 2.  The role of prolactin in mammary carcinoma.

Authors:  Charles V Clevenger; Priscilla A Furth; Susan E Hankinson; Linda A Schuler
Journal:  Endocr Rev       Date:  2003-02       Impact factor: 19.871

Review 3.  Prolactin and breast cancer etiology: an epidemiologic perspective.

Authors:  Shelley S Tworoger; Susan E Hankinson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-02-02       Impact factor: 2.673

4.  Factors that promote the development of human breast cancer.

Authors:  D B Thomas
Journal:  Environ Health Perspect       Date:  1983-04       Impact factor: 9.031

5.  Prolactin and total lactogenic hormone measured by microbioassay and immunoassay in breast cancer.

Authors:  P R Maddox; D L Jones; R E Mansel
Journal:  Br J Cancer       Date:  1992-03       Impact factor: 7.640

6.  Circulating levels of testosterone, 17 beta-oestradiol, luteinising hormone and prolactin in postmenopausal breast cancer patients.

Authors:  G Secreto; C Recchione; A Cavalleri; M Miraglia; V Dati
Journal:  Br J Cancer       Date:  1983-02       Impact factor: 7.640

7.  Plasma lipids and prolactin in patients with breast cancer.

Authors:  I A Bani; C M Williams; P S Boulter; J W Dickerson
Journal:  Br J Cancer       Date:  1986-09       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.